Dr. Szabo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-9050
Education & Training
- UMass Chan Medical SchoolFellowship, Gastroenterology, 1997 - 2000
- UMass Chan Medical SchoolResidency, Internal Medicine, 1994 - 1997
- University of Debrecen Medical and Health Science CenterClass of 1984
Certifications & Licensure
- MA State Medical License 1996 - 2025
Awards, Honors, & Recognition
- Fellow AASLD, 2015
- Fellow (AGAF) American Gastroenterological Association, 2011
Clinical Trials
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment Start of enrollment: 2000 Jun 01
- HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- 414 citationsInflammasome activation and function in liver diseaseGyongyi Szabo, Jan Petrasek
Nature Reviews. Gastroenterology & Hepatology. 2015-07-01 - 115 citationsRole of the Inflammasome in Liver Disease.Marcelle de Carvalho Ribeiro, Gyongyi Szabo
Annual Review of Pathology. 2022-01-24 - 452 citationsDiagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver DiseasesDavid W. Crabb, Gene Y. Im, Gyongyi Szabo, Jessica L. Mellinger, Michael R. Lucey
Hepatology. 2020-01-01
Other
- Hepatitis C and alcoholSzabo G, Marshall CA, Chopra S
http://www.uptodate.com/contents/hepatitis-c-and-alcohol
UpToDate, Wolters Kluwer Health - 2013-03-06
Press Mentions
- BIDMC Awarded $9.1 Million to Advance Assessment and Treatment of Brain Disorders in WomenNovember 1st, 2024
- BIDMC's Bradford Lowell, MD, PhD, Elected to the National Academy of SciencesMay 8th, 2023
- CND Life Sciences Enters into Licensing and Collaboration Agreement to Advance Diagnostic Technology for Neurodegenerative DiseasesMarch 22nd, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: